placeholder image

A. Jatoi All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. 

    • Contact

    full name

  • A. Jatoi

    • Quick Info

    Publications

    Collaboration